Ligand Pharmaceuticals Market Sentiment

Ligand Pharmaceuticals Inc

LGNDNASDAQ

$311.13

9.323.09%

Dern. MÀJ: Oct 12, 3:59 PM

Aperçu Actualités Prévisions de résultats Événements Objectifs de cours Données financièresSentimentActionnariat Comparer Options Rapport sur les stocks

Ligand Pharmaceuticals Market Sentiment

Market sentiment signals for Ligand Pharmaceuticals (LGND): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▼ 16.1% short float

Options Flow▲ 0.33 P/C ratio

Insider Activity▼ Net Seller (30d)

Analyst Consensus

Buy

12 analysts

Options Flow (P/C)

0.33

More calls — Bullish

3 calls · 1 puts

Avg Consensus PT

$302

-3.1%

Highest Price Target

$397

+27.6%

Citigroup

Lowest Price Target

$140

-55.0%

Craig-Hallum

Short Interest

16.1%

Rising — Bearish

Insider Activity (30d)

Net Seller

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Sep 25, 2026	Barclays	Glen Santangelo—	+10.9%	$345	Initiate	Overweight
Sep 24, 2026	HC Wainwright & Co.	Joseph Pantginis—	+15.1%	$358 → $358	Maintained	Buy
Sep 23, 2026	Citigroup	Yigal Nochomovitz—	+27.6%	$390 → $397	Maintained	Buy
Aug 14, 2026	Leerink Partners	David Risinger—	+6.1%	$330	Initiate	Outperform
Aug 7, 2026	RBC Capital	Douglas Miehm—	+10.9%	$340 → $345	Maintained	Outperform
Aug 6, 2026	HC Wainwright & Co.	Joseph Pantginis—	+15.1%	$289 → $358	Maintained	Buy
Aug 3, 2026	Oppenheimer	Leland Gershell—	+4.8%	$285 → $326	Maintained	Outperform
Jul 21, 2026	Citigroup	Yigal Nochomovitz—	+24.4%	$387	Reinstates	Buy
Jul 15, 2026	RBC Capital	Douglas Miehm—	+9.3%	$262 → $340	Maintained	Outperform
Jul 9, 2026	B of A Securities	Jason Zemansky—	+24.7%	$266 → $388	Maintained	Buy
Jul 8, 2026	Stifel	Annabel Samimy—	+6.7%	$255 → $332	Maintained	Buy
May 8, 2026	RBC Capital	Douglas Miehm—	-15.8%	$252 → $262	Maintained	Outperform
Apr 30, 2026	HC Wainwright & Co.	Joseph Pantginis—	-7.1%	$243 → $289	Maintained	Buy
Apr 28, 2026	RBC Capital	Douglas Miehm—	-19.0%	$235 → $252	Maintained	Outperform
Apr 15, 2026	Citigroup	Yigal Nochomovitz—	-9.3%	$276 → $282	Maintained	Buy
Apr 14, 2026	HC Wainwright & Co.	Joseph Pantginis—	-21.9%	$239 → $243	Maintained	Buy
Mar 24, 2026	Citigroup	Yigal Nochomovitz—	-11.3%	$270 → $276	Maintained	Buy
Mar 11, 2026	B of A Securities	Jason Zemansky—	-21.6%	$244	Initiate	Buy
Feb 27, 2026	Oppenheimer	Trevor Allred—	-10.9%	$275 → $277	Maintained	Outperform
Feb 24, 2026	HC Wainwright & Co.	Joseph Pantginis—	-23.2%	$231 → $239	Maintained	Buy
Dec 10, 2025	RBC Capital	Douglas Miehm—	-24.5%	$234 → $235	Maintained	Outperform
Dec 10, 2025	Stifel	Annabel Samimy—	-26.1%	$220 → $230	Maintained	Buy
Dec 9, 2025	Citigroup	Yigal Nochomovitz—	-13.2%	$270	Initiate	Buy
Nov 10, 2025	RBC Capital	Douglas Miehm—	-24.8%	$185 → $234	Maintained	Outperform
Nov 7, 2025	Oppenheimer	Trevor Allred—	-11.6%	$250 → $275	Maintained	Outperform